Current Issue

Feb 02, 2018
BioPharm International
Experts share insights on the various methods used for purity and impurity analysis of therapeutic proteins.
Feb 01, 2018
BioPharm International
The approaches for sample preparation of preclinical evaluation of safety and efficacy are addressed taking into consideration the shortcoming with the contemporary approaches.
Feb 01, 2018
BioPharm International
Single-use technologies are starting to gain ground as capacity needs change, but industrywide adoption remains low.
Feb 01, 2018
BioPharm International
Regardless of the phase of development and the level of GMPs being applied, there should be adequate controls and knowledge to assure patient safety, according to Susan Schniepp, fellow at Regulatory Compliance Associates.
Feb 01, 2018
BioPharm International
Manufacturers tackle regulatory and competitive issues to develop complex therapies and biosimilars.
Feb 01, 2018
BioPharm International
Greater clarity on the application of existing regulations will accelerate development of cell and gene therapies.
Feb 01, 2018
BioPharm International
Frustrated with high costs and drug shortages, hospitals adopt a DIY approach.
Feb 01, 2018
BioPharm International
As closure integrity testing moves from a probabilistic to a deterministic basis, designs are promoting improved control and reduced operator contact.
Feb 01, 2018
BioPharm International
Layout and supply details must be considered when implementing a fully disposable biopharmaceutical manufacturing process.
Feb 01, 2018
BioPharm International
Steve Hayward, product marketing manager at BIOVIA, Dassault Systèmes, discusses the importance of both technology and people in the modern laboratory.
native1_300x100
lorem ipsum